Evidence map›Paper›PMID 18437207›Full record

ReviewPLoS genetics2008

Defining the role of the MHC in autoimmunity: a review and pooled analysis.

Michelle M A Fernando, Christine R Stevens, Emily C Walsh, Philip L De Jager, Philippe Goyette, Robert M Plenge, Timothy J Vyse, John D Rioux

Open access · goldAbstract readReview
In one paragraph

Review in PLoS genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 259 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
259citing papers in PubMed, 8 pooled it
19.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

259 citing papers in PubMed, 8 syntheses or guidelines pooled it, 598 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. PTPN22 R620W Polymorphism is Associated with Myasthenia Gravis Risk: A Systematic Review and Meta-Analysis.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. [Role of HLA genetic variants in autoimmune diseases].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Machine learning in AIRR diagnostics: Advances and applications.Immunoinformatics (Amsterdam, Netherlands) · 2025
    Article
  20. Review

199 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Michelle M A FernandoSection of Molecular Genetics and Rheumatology, Faculty of Medicine, Imperial College London, London, United Kingdom.
Christine R Stevens
Emily C Walsh
Philip L De Jager
Philippe Goyette
Robert M Plenge
Timothy J Vyse
John D Rioux
Harvard University · USImperial College London · GBBrigham and Women's Hospital · USBroad Institute · USMassachusetts Institute of Technology · USMontreal Heart Institute · CA

Funding

The Slamf3, Slamf5, and Slamf6 receptor-induced pathways to murine lupusP01AI065687 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TERHORST, CORNELIS P · 2006 to 2016
$14.7M
Systemic Lupus Erythematosus and Ulcerative Colitis StudyU19AI067152 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KLARESKOG, LARS · 2005 to 2009
$10.1M
Universite de Montreal IBD Genetics Research CenterU01DK062432 · NIDDK · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI John D. Rioux · 2002 to 2026
$9.6M
Identification of the IBD genes on chromosomes 3p and 6pR01DK064869 · NIDDK · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI RIOUX, JOHN D. · 2003 to 2016
$7.8M
Exploration of the Genetic Basis of Multiple SclerosisK08NS046341 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI DE JAGER, PHILIP L · 2003 to 2007
$876k
Mapping HIV/AIDS genes with haplotype-based strategiesK08AI055314 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI PLENGE, ROBERT M · 2004 to 2008
$585k
Arthritis Research UK 16211NIAID NIH HHS AI065687NIAID NIH HHS AI067152NIAID NIH HHS K08 AI055314NIAID NIH HHS K08 AI55314-3NIAID NIH HHS P01 AI065687NIAID NIH HHS U19 AI067152NIDDK NIH HHS DK062432NIDDK NIH HHS DK064869NIDDK NIH HHS R01 DK064869NIDDK NIH HHS U01 DK062432NINDS NIH HHS K08 NS046341NINDS NIH HHS K08 NS46341Wellcome Trust
6 · The paper itself

Abstract

The major histocompatibility complex (MHC) is one of the most extensively studied regions in the human genome because of the association of variants at this locus with autoimmune, infectious, and inflammatory diseases. However, identification of causal variants within the MHC for the majority of these diseases has remained difficult due to the great variability and extensive linkage disequilibrium (LD) that exists among alleles throughout this locus, coupled with inadequate study design whereby only a limited subset of about 20 from a total of approximately 250 genes have been studied in small cohorts of predominantly European origin. We have performed a review and pooled analysis of the past 30 years of research on the role of the MHC in six genetically complex disease traits - multiple sclerosis (MS), type 1 diabetes (T1D), systemic lupus erythematosus (SLE), ulcerative colitis (UC), Crohn's disease (CD), and rheumatoid arthritis (RA) - in order to consolidate and evaluate the current literature regarding MHC genetics in these common autoimmune and inflammatory diseases. We corroborate established MHC disease associations and identify predisposing variants that previously have not been appreciated. Furthermore, we find a number of interesting commonalities and differences across diseases that implicate both general and disease-specific pathogenetic mechanisms in autoimmunity.

Indexed as

Major Histocompatibility ComplexAllelesArthritis, RheumatoidAutoimmunityColitis, UlcerativeCrohn DiseaseDiabetes Mellitus, Type 1Genetic Predisposition to DiseaseHaplotypesHumansLinkage DisequilibriumLupus Erythematosus, SystemicMultiple Sclerosis

Identifiers

PMID18437207
PMCPMC2291482
OpenAlexW2146293362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.